Andrew Mok
Stock Analyst at Barclays
(3.33)
# 921
Out of 5,182 analysts
277
Total ratings
50%
Success rate
0.96%
Average return
Main Sectors:
Stocks Rated by Andrew Mok
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Maintains: Equal-Weight | $23 → $25 | $22.38 | +11.71% | 11 | Mar 25, 2026 | |
| AVAH Aveanna Healthcare Holdings | Maintains: Overweight | $11 → $9.5 | $6.45 | +47.29% | 4 | Mar 25, 2026 | |
| ADUS Addus HomeCare | Maintains: Underweight | $112 → $102 | $93.15 | +9.50% | 6 | Mar 25, 2026 | |
| SGRY Surgery Partners | Maintains: Equal-Weight | $18 → $14 | $12.64 | +10.76% | 6 | Mar 3, 2026 | |
| ACHC Acadia Healthcare Company | Maintains: Equal-Weight | $14 → $20 | $25.39 | -21.23% | 21 | Mar 3, 2026 | |
| AGL agilon health | Maintains: Underweight | $25 → $13 | $16.59 | -24.65% | 6 | Feb 27, 2026 | |
| UHS Universal Health Services | Maintains: Overweight | $262 → $268 | $180.61 | +48.39% | 27 | Feb 26, 2026 | |
| HUM Humana | Maintains: Equal-Weight | $245 → $176 | $197.15 | -10.73% | 16 | Feb 25, 2026 | |
| HCA HCA Healthcare | Maintains: Buy | $598 → $635 | $489.58 | +29.70% | 18 | Feb 23, 2026 | |
| THC Tenet Healthcare | Maintains: Overweight | $240 → $257 | $194.60 | +32.07% | 17 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $164 → $133 | $141.53 | -6.03% | 12 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $150 → $153 | $105.67 | +44.79% | 19 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $305 → $303 | $274.25 | +10.48% | 11 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $186 → $190 | $149.70 | +26.92% | 15 | Feb 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $18 | $13.75 | +30.91% | 3 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $391 → $327 | $307.73 | +6.26% | 15 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $404 → $393 | $311.83 | +26.03% | 16 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $13 → $18 | $12.97 | +38.78% | 4 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $44 → $54 | $36.31 | +48.72% | 13 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 → $93 | $78.22 | +18.90% | 12 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $36 → $26 | $27.75 | -6.31% | 2 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $79 → $86 | $54.58 | +57.57% | 9 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $13 → $18 | $21.66 | -16.90% | 6 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $4 → $3.5 | $3.03 | +15.51% | 7 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $12 | $13.99 | -14.22% | 1 | Dec 8, 2022 |
Privia Health Group
Mar 25, 2026
Maintains: Equal-Weight
Price Target: $23 → $25
Current: $22.38
Upside: +11.71%
Aveanna Healthcare Holdings
Mar 25, 2026
Maintains: Overweight
Price Target: $11 → $9.5
Current: $6.45
Upside: +47.29%
Addus HomeCare
Mar 25, 2026
Maintains: Underweight
Price Target: $112 → $102
Current: $93.15
Upside: +9.50%
Surgery Partners
Mar 3, 2026
Maintains: Equal-Weight
Price Target: $18 → $14
Current: $12.64
Upside: +10.76%
Acadia Healthcare Company
Mar 3, 2026
Maintains: Equal-Weight
Price Target: $14 → $20
Current: $25.39
Upside: -21.23%
agilon health
Feb 27, 2026
Maintains: Underweight
Price Target: $25 → $13
Current: $16.59
Upside: -24.65%
Universal Health Services
Feb 26, 2026
Maintains: Overweight
Price Target: $262 → $268
Current: $180.61
Upside: +48.39%
Humana
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $245 → $176
Current: $197.15
Upside: -10.73%
HCA Healthcare
Feb 23, 2026
Maintains: Buy
Price Target: $598 → $635
Current: $489.58
Upside: +29.70%
Tenet Healthcare
Feb 13, 2026
Maintains: Overweight
Price Target: $240 → $257
Current: $194.60
Upside: +32.07%
Feb 10, 2026
Maintains: Underweight
Price Target: $164 → $133
Current: $141.53
Upside: -6.03%
Feb 6, 2026
Maintains: Overweight
Price Target: $150 → $153
Current: $105.67
Upside: +44.79%
Feb 6, 2026
Maintains: Overweight
Price Target: $305 → $303
Current: $274.25
Upside: +10.48%
Feb 4, 2026
Maintains: Buy
Price Target: $186 → $190
Current: $149.70
Upside: +26.92%
Feb 3, 2026
Maintains: Overweight
Price Target: $15 → $18
Current: $13.75
Upside: +30.91%
Jan 30, 2026
Maintains: Overweight
Price Target: $391 → $327
Current: $307.73
Upside: +6.26%
Jan 30, 2026
Maintains: Overweight
Price Target: $404 → $393
Current: $311.83
Upside: +26.03%
Jan 5, 2026
Upgrades: Equal-Weight
Price Target: $13 → $18
Current: $12.97
Upside: +38.78%
Jan 5, 2026
Upgrades: Overweight
Price Target: $44 → $54
Current: $36.31
Upside: +48.72%
Dec 10, 2025
Maintains: Overweight
Price Target: $87 → $93
Current: $78.22
Upside: +18.90%
Nov 24, 2025
Maintains: Equal-Weight
Price Target: $36 → $26
Current: $27.75
Upside: -6.31%
Nov 13, 2025
Maintains: Overweight
Price Target: $79 → $86
Current: $54.58
Upside: +57.57%
Nov 3, 2025
Maintains: Equal-Weight
Price Target: $13 → $18
Current: $21.66
Upside: -16.90%
Jul 24, 2025
Maintains: Equal-Weight
Price Target: $4 → $3.5
Current: $3.03
Upside: +15.51%
Dec 8, 2022
Initiates: Sell
Price Target: $12
Current: $13.99
Upside: -14.22%